Research Output per year
Fingerprint Dive into the research topics where Pamela Maxwell is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 54 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinoma
LaBonte Wilson, M., Ong, C. W., Armstrong, C., Waugh, D., Maxwell, P., O'Sullivan, J., Prise, K., Butterworth, K., Coulter, J., Walker, S., Oksana, L., Gallagher, R., Jain, S., Bristow, R. G. & Mills, I., 03 Jul 2020, In : NAR Cancer. 2, 3Research output: Contribution to journal › Article
Open Access
File
A gene signature associated with PTEN activation defines good prognosis intermediate-risk prostate cancer cases
Ong, C. W., Maxwell, P., Alvi, M. A., McQuaid, S., Waugh, D., Mills, I. & Salto-Tellez, M., 28 Feb 2018, In : The Journal of Pathology: Clinical Research.Research output: Contribution to journal › Article
Open Access
File
6
Citations
(Scopus)
239
Downloads
(Pure)
Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonists
McCann, C., Crawford, N., Majkut, J., Holohan, C., Armstrong, C., Maxwell, P., Ong, C. W., LaBonte Wilson, M., McDade, S., Waugh, D. & Longley, D., 22 Oct 2018, In : Cell, Death & Disease. 9, 1081, 13 p., 1081.Research output: Contribution to journal › Article
Open Access
File
4
Citations
(Scopus)
199
Downloads
(Pure)
Radio-resistance of PTEN-deficient prostate tumours is enhanced by treatment-induced chemokine signalling and is associated with biochemical recurrence and development of metastasis.
Armstrong, C., Coulter, J., Ong, C. W., Maxwell, P., Butterworth, K., Oksana, L., Berlingeri, S., LaBonte Wilson, M., Walker, S., O'Sullivan, J., Salto-Tellez, M., Jain, S., Mills, I., Illidge, T., Kennedy, R., Prise, K. & Waugh, D., 01 Aug 2018.Research output: Contribution to conference › Poster
Enhanced radio-sensitivity of PTEN-deficient prostate tumours mediated by inhibition of intrinsic and treatment-potentiated CXC-chemokine signaling
Armstrong, C., Coulter, J., Ong, C. W., Maxwell, P., LaBonte Wilson, M., Butterworth, K., Lyubomska, O., Berlingeri, S., Gallagher, R., Walker, S., O'Sullivan, J., Mills, I., Salto-Tellez, M., Illidge, T., Bristow, R. G., Kennedy, R., Prise, K. & Waugh, D., 2017.Research output: Contribution to conference › Poster